Sökresultat

Filtyp

Din sökning på "*" gav 537561 sökträffar

How to turn research ideas into a real-world impact

Professors Thoas Fioretos, Lao Saal, Carl Borrebaeck and Åke Borg are behind some of the most promising companies and approaches within diagnostics and treatment emerging from cancer research at Lund University. Photo: Tove Smeds, Olle Dahlbäck. Professors Carl Borrebaeck, Thoas Fioretos, Lao Saal and Åke Borg share their experiences in transforming groundbreaking research into diagnostic tools, t

https://www.medicine.lu.se/article/how-turn-research-ideas-real-world-impact - 2025-09-15

Charlotte Ling receives major grant for clinical diabetes research

Charlotte Ling, who together with Katarina Fagher and Alice Maguolo, has been awarded a grant of five million Danish kroner by the Novo Nordisk Foundation. Photo: Kennet Ruona Congratulations to Charlotte Ling who, together with Katarina Fagher and Alice Maguolo, has been awarded a grant of five million Danish kroner by the Novo Nordisk Foundation. The funding will support clinical research in pre

https://www.medicine.lu.se/article/charlotte-ling-receives-major-grant-clinical-diabetes-research - 2025-09-15

Brain activation pattern behind impulsivity in Parkinson’s treatment discovered

he researchers stained brain sections to identify how different Parkinson’s treatments activate distinct brain circuits. Photo: Emma Nyberg. An experimental study from Lund University reveals for the first time that different Parkinson’s medications affect brain activity in distinct ways. This could explain why some patients develop impulsive and compulsive behaviors as a result of their treatment

https://www.medicine.lu.se/article/brain-activation-pattern-behind-impulsivity-parkinsons-treatment-discovered - 2025-09-15

Brussels meeting: Advancing personalised treatment for childhood AML across Europe

The NOPHO-DB-SHIP consortium at last year's meeting in Utrecht, NL. Photo: Private In June, pediatric cancer experts from 16 countries gathered in Brussels for the annual meeting of the NOPHO-DB-SHIP consortium—an EU-wide collaboration working to improve outcomes for children with Acute Myeloid Leukemia (AML). In Sweden, the trial is coordinated by Lund University and Skåne University Hospital. At

https://www.medicine.lu.se/article/brussels-meeting-advancing-personalised-treatment-childhood-aml-across-europe - 2025-09-15

Aggressive skin cancer driven by mitochondrial processes –existing drugs offer promising treatment path

Jeovanis Gil, researcher in clinical chemistry at Lund University, focuses extensively on understanding mitochondrial roles in melanoma and other cancers. Photo: Tove Smeds A new study led by researchers at Lund University in Sweden, reveals that melanoma, the deadliest form of skin cancer, can in some cases be driven by mitochondrial processes, which can be effectively targeted using existing dru

https://www.medicine.lu.se/article/aggressive-skin-cancer-driven-mitochondrial-processes-existing-drugs-offer-promising-treatment-path - 2025-09-15

Biomarkers reveal risk of cardiovascular disease in type 2 diabetes

Charlotte Ling and colleagues want to develop a kit for clinical use to predict the risk of cardiovascular disease in type 2 diabetes: a simple blood test that measures DNA methylation and a scoring scale that predicts the risk of disease. Photo: K Ruona. An international research team led from Lund University, has identified epigenetic biomarkers that can predict which people with type 2 diabetes

https://www.medicine.lu.se/article/biomarkers-reveal-risk-cardiovascular-disease-type-2-diabetes - 2025-09-15

Children waiting for a new heart –study shows marked improvement in survival rates and the importance of Nordic cooperation

The researchers have mapped how the outcomes for heart-transplanted children have changed over time and examined how the results compare in an international context. Photo: iStock In a new observational study, researchers at Lund University in Sweden looked at all children listed for heart transplants in the Nordic countries between 1986 and 2023. A total of 597 children were included in the study

https://www.medicine.lu.se/article/children-waiting-new-heart-study-shows-marked-improvement-survival-rates-and-importance-nordic - 2025-09-15

Hjelt Diabetes Foundation supports research that can pave the way for new cell therapies

Sevda Gheibi studies a protein called ACSL1 that seems to play a key role for beta cell function. She receives a grant of from the Hjelt Diabetes Foundation for further studies of this protein. Photo: Petra Olsson Type 2 diabetes is a chronic disease that usually requires lifelong treatment. A central goal for many diabetes researchers is to develop new cell therapies that can cure the disease. Th

https://www.medicine.lu.se/article/hjelt-diabetes-foundation-supports-research-can-pave-way-new-cell-therapies - 2025-09-15

Why repetitive DNA matters for human brain evolution and disease

“An underlying question in my lab is: how did the human brain become human?” says Johan Jakobsson, professor at the Department of Experimental Medical Science and head of the Laboratory of Molecular Neurogenetics For decades, large stretches of human DNA were dismissed as ‘junk’ and considered to serve no real purpose. In a new study in Cell Genomics, researchers at Lund University in Sweden show

https://www.medicine.lu.se/article/why-repetitive-dna-matters-human-brain-evolution-and-disease-0 - 2025-09-15

Scientists uncover cellular “toolkit” to reprogram immune cells for cancer therapy

Members of the Pereira Lab: Luís Oliveira, Ilia Kurochkin, Filipe Pereira and Abigail Altman. Photo: Kennet Ruona An international team led by researchers at Lund University in Sweden has identified the molecular tools needed to reprogram ordinary cells into specialised immune cells. The discovery, published in Immunity, could pave the way for more precise and personalised cancer immunotherapies.

https://www.medicine.lu.se/article/scientists-uncover-cellular-toolkit-reprogram-immune-cells-cancer-therapy - 2025-09-15

Urine test can assess risk of kidney cancer recurrence

A new international study with 134 patients from 23 hospitals in ten countries shows that a simple urine test can cut the number of radiological examinations in half. Photo: iStock A simple urine test that can assess the risk of kidney cancer recurrence at an early stage could spare patients from frequent imaging scans, e.g. CT-scans, and thus reduce the associated radiation, anxiety and costs. Th

https://www.medicine.lu.se/article/urine-test-can-assess-risk-kidney-cancer-recurrence - 2025-09-15

New global initiative on maternal and newborn health to be led from Sweden

Mehreen Zaigham, Associate Professor at Lund University and specialist in Obstetrics and Gynaecology, Skåne University Hospital, is chairing the upcoming Lancet Commission. Photo: Ingemar Hultquist A new international commission will pave the way for a global boost in maternal and newborn health. The project is led by a researcher at Lund University in Sweden, whose motivation stems from a formati

https://www.medicine.lu.se/article/new-global-initiative-maternal-and-newborn-health-be-led - 2025-09-15

ERC grants awarded to research on the interplay between immunology and fertility, and Alzheimer's disease

Jacob Vogel and Camila Consiglio are awarded The European Research Council (ERC) Starting Grants to develop their research projects and to building their own research team. Photo: Ingemar Hultquist Congratulations to Jacob Vogel and Camila Consiglio who have been awarded grants to develop their research projects on Alzheimer's and fertility. Camila Consiglio's research focuses on infertility and t

https://www.medicine.lu.se/article/erc-grants-awarded-research-interplay-between-immunology-and-fertility-and-alzheimers-disease - 2025-09-15

Highlights from the Lund Spring Symposium 2025

Lars Grundemar is head of research group and adjunct professor of clinical pharmacology at Lund University, and the initiator and chair of the Lund Spring Symposium. Photo: Tove Smeds From Nobel Prizes to visions of the future – over a few days in May, world-leading medical researchers and biotech pioneers gathered to discuss new molecular therapies: from genetic fundamentals to clinical breakthro

https://www.medicine.lu.se/article/highlights-lund-spring-symposium-2025 - 2025-09-15

Science, Responsibility and Resilience – A Conversation on the Future of Medicines

Mikael Dolsten (left) and Jan M. Lundberg (center) in a conversation moderated by Adam Smith, Nobel Prize Outreach (right). Photo: Tove Smeds. At this year’s Lund Spring Symposium, two veteran leaders of pharmaceutical research – Jan M. Lundberg and Mikael Dolsten – engaged in a wide-ranging conversation about scientific courage, setbacks, technological leaps, and hope for the future. The 2025 edi

https://www.medicine.lu.se/article/science-responsibility-and-resilience-conversation-future-medicines - 2025-09-15

RNAi: A Genetic Spark in the Information Inferno of the Cell

Nobel Laureate in Physiology or Medicine 2006, Craig Mello, professor at the University of Massachusetts, Chan Medical School, USA. Photo: Tove Smeds. The information age predates the internet by a long stretch – it began with life itself. Nobel Laureate Craig C. Mello described at the Lund Spring Symposium in May how living organisms are not merely carriers of genes, but also active managers, def

https://www.medicine.lu.se/article/rnai-genetic-spark-information-inferno-cell - 2025-09-15

Rewriting Genetic Fate: Katherine High and the Rise of Gene Therapy

Kathrine High, visiting professor at Rockefeller University, CEO of RhyGaze AG, and former president and chief scientific officer at Spark Therapeutics. Photo: Tove Smeds. LUND SPRING SYMPOSIUM – When Katherine A. High began working with gene therapy, the field was new, promising – and riddled with uncertainty. Three decades later, she is a visiting professor at The Rockefeller University, CEO of

https://www.medicine.lu.se/article/rewriting-genetic-fate-katherine-high-and-rise-gene-therapy - 2025-09-15

Innovative ideas and pioneering solutions from Lund University celebrated

Yvonne Lundberg Giwercman received the award for the development of a point-of-care test that can greatly improve the outcome of IVF treatments. An innovative IVF test and a methane detector – these are some of the future innovation stars developed at Lund University. They are now being recognised by the University and Sparbanken Skåne. Since its launch in 2017, the Future Innovations Award has re

https://www.medicine.lu.se/article/innovative-ideas-and-pioneering-solutions-lund-university-celebrated - 2025-09-15

Award-winning cancer researcher revolutionises diagnosis and treatment worldwide

"Stronger support functions such as LU Innovation, incubators and Medicon Village in Lund have been developed in a fantastic way and enable research to be transformed more quickly into solutions that reach wider society,” says Thoas Fioretos. Professor Thoas Fioretos is the first recipient of Lunds Innovatörspris (the Lund Innovator Award), a newly established prize that recognises research that h

https://www.medicine.lu.se/article/award-winning-cancer-researcher-revolutionises-diagnosis-and-treatment-worldwide - 2025-09-15

New digital cognitive test for diagnosing Alzheimer's disease

The digital test is done by the patient individually on a tablet computer. The test measures: memory, cognitive processing speed and attention. Photo: iStock Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. “This digital test, which patients perform on their own with minimal involvement fro

https://www.medicine.lu.se/article/new-digital-cognitive-test-diagnosing-alzheimers-disease - 2025-09-15